Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:4:57-71.
doi: 10.2147/IJNRD.S7032. Epub 2011 Mar 31.

Tolvaptan, hyponatremia, and heart failure

Affiliations

Tolvaptan, hyponatremia, and heart failure

Hammam D Zmily et al. Int J Nephrol Renovasc Dis. 2011.

Abstract

Tolvaptan is the first FDA-approved oral V(2) receptor antagonist for the treatment of euvolemic and hypervolemic hyponatremia, in patients with conditions associated with free water excess such as heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone secretion. Tolvaptan inhibits the binding of arginine vasopressin to the V(2) receptors on the collecting ducts of the kidneys resulting in aquaresis, the electrolytes sparing excretion of water. This article reviews the accumulated experience with tolvaptan and all the major clinical trials that were conducted to study its safety and efficacy and concludes by summarizing clinicians' views of its current application in clinical practice.

Keywords: arginine vasopressin antagonist; heart failure; hyponatremia; tolvaptan.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ghali JK. Mechanisms, risks, and new treatment options for hyponatremia. Cardiology. 2008;111:147–157. - PubMed
    1. Renneboog B, Vendemergel X, Manto MN, et al. Mild chronic hyponatremia is associated with falls, unsteadiness and attention deficits. Am J Med. 2006;119:71e1–71e8. - PubMed
    1. Sandhu HS, Gilles E, DeVita MV, et al. Hyponatremia associated with large bone fracture in elderly patients. Int Urol Nephrol. 2009;41:733–737. - PubMed
    1. Kinsell S, Moran S, Sullivan MO, et al. Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol. 2010;5:275–280. - PMC - PubMed
    1. Gankam Kengne F, Andres C, Sattar L, et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM. 2008;101:583–588. - PubMed

LinkOut - more resources